Maravai LifeSciences (MRVI) News Today $4.42 -0.78 (-15.00%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Maravai LifeSciences (NASDAQ:MRVI) Earns Peer Perform Rating from Analysts at Wolfe ResearchNovember 16 at 2:09 AM | americanbankingnews.comMaravai LifeSciences (NASDAQ:MRVI) Stock Price Down 7.5% - Here's What HappenedMaravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5% - Here's What HappenedNovember 15 at 2:50 PM | marketbeat.comMaravai Lifesciences initiated with a Peer Perform at Wolfe ResearchNovember 15 at 5:04 AM | markets.businessinsider.comWolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform RecommendationNovember 15 at 5:04 AM | msn.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Up on Insider Buying ActivityNovember 15 at 1:41 AM | americanbankingnews.comMaravai LifeSciences (NASDAQ:MRVI) Coverage Initiated by Analysts at Wolfe ResearchWolfe Research assumed coverage on shares of Maravai LifeSciences in a research note on Thursday. They set a "peer perform" rating for the company.November 14 at 8:14 AM | marketbeat.comMaravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 1,002 put options on the company. This represents an increase of approximately 1,791% compared to the typical daily volume of 53 put options.November 14 at 4:46 AM | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying ActivityMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Up After Insider Buying ActivityNovember 13, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Insider Buys $987,000.00 in StockNovember 13, 2024 | insidertrades.comMaravai LifeSciences Announces November 2024 Investor Conference ScheduleNovember 12, 2024 | globenewswire.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target PriceNovember 10, 2024 | finance.yahoo.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst DowngradeNovember 10, 2024 | americanbankingnews.comMaravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comHold Rating on Maravai Lifesciences: Revenue Miss, Guidance Cut, and Market Challenges Amid Potential Upside from Officinae Bio AcquisitionNovember 9, 2024 | markets.businessinsider.comMaravai Lifesciences price target lowered to $13 from $17 at RBC CapitalNovember 9, 2024 | markets.businessinsider.comMaravai LifeSciences Shares Plunge 39% After Guidance Cut, 3Q MissNovember 9, 2024 | marketwatch.comBank of America Securities Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)November 9, 2024 | markets.businessinsider.comWilliam Blair Downgrades Maravai LifeSciences Holdings (MRVI)November 9, 2024 | msn.comMaravai LifeSciences stock plunges 39% amid lowered revenue forecastNovember 9, 2024 | seekingalpha.comMaravai Lifesciences Holdings (MRVI) Gets a Buy from Craig-HallumNovember 9, 2024 | markets.businessinsider.comRoyal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock PriceRoyal Bank of Canada decreased their price target on Maravai LifeSciences from $17.00 to $13.00 and set an "outperform" rating for the company in a research note on Friday.November 8, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down After Analyst DowngradeMaravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst DowngradeNovember 8, 2024 | marketbeat.comRobert W. Baird Cuts Maravai LifeSciences (NASDAQ:MRVI) Price Target to $9.00Robert W. Baird decreased their price target on shares of Maravai LifeSciences from $10.00 to $9.00 and set an "outperform" rating on the stock in a research note on Friday.November 8, 2024 | marketbeat.comWilliam Blair Reiterates Market Perform Rating for Maravai LifeSciences (NASDAQ:MRVI)William Blair reiterated a "market perform" rating on shares of Maravai LifeSciences in a research note on Friday.November 8, 2024 | marketbeat.comMaravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid ResearchNovember 8, 2024 | finance.yahoo.comCannon Global Investment Management LLC Buys New Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Cannon Global Investment Management LLC bought a new stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 71,000 shares of the coNovember 3, 2024 | marketbeat.comRoubaix Capital LLC Has $1.98 Million Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Roubaix Capital LLC trimmed its holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 45.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 237,747 shares of the company's stockOctober 31, 2024 | marketbeat.comMaravai LifeSciences (MRVI) to Release Earnings on ThursdayMaravai LifeSciences (NASDAQ:MRVI) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635822)October 31, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Trading 7% Higher - Here's WhyMaravai LifeSciences (NASDAQ:MRVI) Trading Up 7% - What's Next?October 30, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Rating of "Moderate Buy" by AnalystsShares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine brokerages that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and six have issued a bOctober 28, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Shares Down 4.6% - Here's WhyMaravai LifeSciences (NASDAQ:MRVI) Trading Down 4.6% - Time to Sell?October 22, 2024 | marketbeat.comMaravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024October 15, 2024 | globenewswire.comDimensional Fund Advisors LP Has $4.71 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Dimensional Fund Advisors LP reduced its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 18.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 658,397 sharesOctober 10, 2024 | marketbeat.comRGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 LetterOctober 9, 2024 | msn.comMaravai LifeSciences Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)October 8, 2024 | benzinga.comThe Goldman Sachs Group Trims Maravai LifeSciences (NASDAQ:MRVI) Target Price to $7.00The Goldman Sachs Group lowered their price target on shares of Maravai LifeSciences from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Tuesday.October 8, 2024 | marketbeat.comClearbridge Investments LLC Has $7.55 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Clearbridge Investments LLC lifted its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 31.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,054,109 shares of the company's stockOctober 6, 2024 | marketbeat.com150,878 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Acquired by Algert Global LLCAlgert Global LLC bought a new position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 150,878 shares of the company's stock, valued at approximately $1,080October 5, 2024 | marketbeat.comMaravai LifeSciences (NASDAQ:MRVI) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comMaravai LifeSciences (NASDAQ:MRVI) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comSquarepoint Ops LLC Has $2.55 Million Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Squarepoint Ops LLC increased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 181.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 355,590 shares of the company's stockOctober 3, 2024 | marketbeat.comMaravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold ratingOctober 3, 2024 | marketbeat.comMaravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) saw unusually large options trading activity on Wednesday. Traders purchased 1,002 put options on the stock. This represents an increase of 1,791% compared to the average volume of 53 put options.October 3, 2024 | marketbeat.comMillennium Management LLC Has $42.74 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Millennium Management LLC increased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 12.3% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 5,968,592 shares of the company's stock after purchasing an additional 653,639 shaOctober 2, 2024 | marketbeat.comCubist Systematic Strategies LLC Has $2.03 Million Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Cubist Systematic Strategies LLC trimmed its stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 21.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 284,146 shares of the company's stock afteOctober 1, 2024 | marketbeat.comSystematic Financial Management LP Reduces Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Systematic Financial Management LP cut its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 6.6% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,405,662 shares of the compSeptember 30, 2024 | marketbeat.comMackenzie Financial Corp Increases Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Mackenzie Financial Corp increased its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 16.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,860,641 shares of the company's stockSeptember 29, 2024 | marketbeat.comPoint72 Asset Management L.P. Increases Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Point72 Asset Management L.P. grew its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 149.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,519,561 shares of the cSeptember 27, 2024 | marketbeat.comDragoneer Investment Group LLC Buys Shares of 750,468 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)Dragoneer Investment Group LLC bought a new position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 750,468 shares of the compSeptember 26, 2024 | marketbeat.com Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. MRVI Media Mentions By Week MRVI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRVI News Sentiment▼0.540.56▲Average Medical News Sentiment MRVI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRVI Articles This Week▼164▲MRVI Articles Average Week Get Maravai LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RNA News TGTX News BHVN News ALKS News AXSM News CRNX News BBIO News RARE News PBH News OGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRVI) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Maravai LifeSciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Maravai LifeSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
